US Patent 7404953 Methods using eosinophil-specific apoptosis inducer
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Emi Hosaka0
Kazuyasu Nakamura0
Kenya Shitara0
Masamichi Koike0
Nobuo Hanai0
Edits on 14 Sep, 2023
Golden AI
Edits made to:
Article (+432 characters)
Article
Patent abstract
The present invention provides an apoptosis inducer and a therapeutic agent for eosinophilic diseases which comprises, as an active ingredient, an antibody which reacts specifically with eosinophils and induces apoptosis of eosinophils; and a method for inducing eosinophil apoptosis using the antibody, and a method for specifically reducing or removing eosinophils in peripheral blood or tissues using the antibody.
Edits on 14 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07404953 Methods using eosinophil-specific apoptosis inducer US Patent 7404953 Methods using eosinophil-specific apoptosis inducer
Infobox
Patent Number
074049530
Patent Number
74049530
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 29 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
074049530
Date of Patent
July 29, 2008
0Patent Application Number
102043260
Date Filed
February 15, 2001
0Official Website
Patent Primary Examiner
Edits on 9 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 30 Nov, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07404953 Methods using eosinophil-specific apoptosis inducer
Infobox
Is a
Patent jurisdiction
Patent number
07404953
Date of patent
July 29, 2008
Patent application number
10204326
Date Filed
February 15, 2001
Patent primary examiner
Find more entities like US Patent 7404953 Methods using eosinophil-specific apoptosis inducer
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
